ClinicalTrialsFinder

Burjeel Medical City ( Site 2600)

Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates

1 recruiting

Showing 1–1 of 1 trials

Recruiting
Phase 3

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

Non-small Cell Lung CancerNSCLC
Merck Sharp & Dohme LLC851 enrolled204 locationsNCT06422143